Stagflation Fears Rise: Investment Strategies for Resilience
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 02 2026
0mins
Should l Buy JNJ?
Source: Fool
- Surge in Stagflation Searches: Google Trends indicates a 650% increase in searches for 'stagflation 2026' over the past three months, highlighting growing market concerns about economic stagnation and high inflation, prompting investors to reassess potential recession risks.
- Deteriorating Job Data: The U.S. lost 92,000 jobs in February, significantly worse than expected, leading to a 40% probability assessment for a U.S. recession, which could negatively impact consumer spending and corporate earnings.
- Energy Stocks Benefit: In a stagflation scenario, ExxonMobil (XOM), the largest energy company in the U.S., stands to gain as rising oil and gas prices boost its revenues and share price, making it a preferred safe haven for investors amid economic uncertainty.
- Defensive Stock Strategy: Johnson & Johnson (JNJ) and Walmart (WMT) are viewed as top defensive investments in a stagnating economy with high inflation, with J&J benefiting from stable demand for medical products and Walmart leveraging its position in low-priced consumer goods to maintain steady returns during stagflation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy JNJ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on JNJ
Wall Street analysts forecast JNJ stock price to fall
20 Analyst Rating
13 Buy
7 Hold
0 Sell
Moderate Buy
Current: 241.310
Low
190.00
Averages
218.50
High
240.00
Current: 241.310
Low
190.00
Averages
218.50
High
240.00
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Confidence Decline: The consumer confidence index has dropped to 56.4, nearing recession levels, prompting a shift towards defensive businesses, and despite flat performance in consumer staples in 2025, there are opportunities to buy at low prices.
- General Mills' Investment Value: General Mills (GIS) is trading at a 15-year low with a year-to-date decline of about 21%, yet its 127-year uninterrupted dividend history and a 6.7% yield make it a reliable choice for long-term passive income.
- Hormel Foods' Resilience: Hormel Foods (HRL) has raised its dividend for 59 consecutive years, and despite a 50% drop from its 2022 peak, its brand leadership and dual position in private-label manufacturing provide a defensive edge.
- Kenvue's Market Potential: Kenvue (KVUE), spun off from Johnson & Johnson, is down 30% from its 52-week high, but its stable product portfolio and analyst support make it an investment worth considering.
See More
- Market Rally: President Trump’s announcement to suspend attacks on Iran led to a surge in the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average, each rising over 2.5% on April 8, with the Dow posting its largest gain in a year, reflecting a short-term market response to eased geopolitical tensions.
- Investor Confidence Restored: Although uncertainty remains, Trump's statement has restored some investor confidence in the stock market, particularly for growth-dependent stocks, which may attract more capital inflows in the near term.
- Long-Term Investment Strategy: History shows that conflicts and market turmoil are temporary, and quality companies typically recover and achieve long-term growth after short-term challenges, prompting investors to focus on firms with strong competitive positions and solid financial health.
- AI Investment Opportunities: In the current market environment, AI stocks like Nvidia, trading at a one-year low valuation, present an ideal choice for growth investors, as their broad product portfolio is expected to drive future market gains.
See More
- Market Rally: Following Trump's announcement to suspend attacks in Iran, the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average each surged over 2.5% on April 8, with the Dow posting its largest gain in a year, reflecting a positive market response to reduced geopolitical risks.
- Oil Price Impact: The ongoing war in Iran has driven up oil prices and disrupted key industrial transit waterways, dampening investor appetite for growth-dependent stocks; however, the ceasefire news has injected short-term optimism that could aid recovery in affected sectors.
- Long-term Investment Strategy: Despite current market uncertainties, history shows that conflicts and economic downturns are temporary, and quality companies can rebound and achieve long-term growth, prompting investors to focus on firms that have demonstrated sustained growth and strong competitive positions over the years.
- Quality Stock Selection: Companies like Amazon and Johnson & Johnson have shown resilience in tough markets, delivering consistent returns, while dividend stocks such as Coca-Cola provide passive income, suggesting that investors should prioritize these quality assets in the current market environment.
See More
- Market Rally: The S&P 500 surged 3.6% this week, driven by President Trump's two-week ceasefire announcement with Iran, while the Nasdaq and Dow gained 4.7% and 3% respectively, reflecting a surge of optimism in the market.
- Investor Caution: Cramer warns that despite the market's rebound, investors should refrain from making hasty decisions due to the ongoing instability in Iran, which could impact the global economy and the critical shipping routes in the Strait of Hormuz.
- Earnings Outlook: Goldman Sachs is set to report earnings on Monday, with Cramer predicting a solid performance from its trading desk, benefiting from market volatility, indicating a potential recovery in the banking sector.
- Industry Dynamics: Next week, major banks like JPMorgan, Wells Fargo, and Citigroup will release earnings, with Cramer highlighting JPMorgan's cautious commentary and Wells Fargo's long-term turnaround strategy, showcasing varied perspectives on the banking industry's future.
See More
- Market Pullback Risk: Stocks edged lower on Friday, putting the S&P 500's seven-day winning streak at risk, as profit-taking emerged after a strong week where the index rose approximately 3.5%, indicating cautious market sentiment.
- Target Price Adjustments: We raised Dover's price target from $220 to $230, anticipating growth across all its business segments in 2026, while noting its limited exposure to the Middle East, which underscores its robust growth potential.
- Strong Demand Outlook: Lumentum's CEO indicated the company is nearly sold out of optical components through 2028, suggesting strong demand, leading to an increase in Corning's price target from $160 to $180, reflecting its pricing power in the optical fiber market for data centers.
- Software Stock Pressure: We lowered the price targets for Salesforce and Microsoft to $215 and $500, respectively, due to ongoing pressure from AI threats in the enterprise software market, which is expected to impact their price-to-earnings multiples, reflecting a cautious outlook on software stocks.
See More
- Market Recovery Signal: Following President Trump's suspension of attacks on Iran, the Dow Jones Industrial Average surged over 1,300 points this week, marking its best single-day performance since April 2025, indicating investor confidence in market recovery.
- Earnings Season Outlook: The S&P 500 companies are expected to report a blended earnings growth rate of 12.5% for Q1, marking the sixth consecutive quarter of double-digit growth, with the information technology sector projected to jump 44%, underscoring its significance to the market.
- Risk Warning: Despite the optimistic overall earnings outlook, Delta Air Lines announced it would
See More











